The surface layer of Tannerella forsythia contributes to serum resistance and oral bacterial coaggregation.
Tannerella forsythia is an anaerobic, Gram-negative bacterium involved in the so-called "red complex," which is associated with severe and chronic periodontitis. The surface layer (S-layer) of T. forsythia is composed of cell surface glycoproteins, such as TfsA and TfsB, and is known to play a role in adhesion/invasion and suppression of proinflammatory cytokine expression. Here we investigated the association of this S-layer with serum resistance and coaggregation with other oral bacteria. The growth of the S-layer-deficient mutant in a bacterial medium containing more than 20% non-heat-inactivated calf serum (CS) or more than 40% non-heat-inactivated human serum was significantly suppressed relative to that of the wild type (WT). Next, we used confocal microscopy to perform quantitative analysis on the effect of serum. The survival ratio of the mutant exposed to 100% non-heat-inactivated CS (76% survival) was significantly lower than that of the WT (97% survival). Furthermore, significant C3b deposition was observed in the mutant but not in the WT. In a coaggregation assay, the mutant showed reduced coaggregation with Streptococcus sanguinis, Streptococcus salivarius, and Porphyromonas gingivalis but strong coaggregation with Fusobacterium nucleatum. These results indicated that the S-layer of T. forsythia plays multiple roles in virulence and may be associated with periodontitis.
Department of Oral Microbiology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Naohiro
N
Shimotahira
Yuichi
Y
Oogai
Miki
M
Kawada-Matsuo
Sakuo
S
Yamada
Kenji
K
Fukutsuji
Keiji
K
Nagano
Fuminobu
F
Yoshimura
Kazuyuki
K
Noguchi
Hitoshi
H
Komatsuzawa
D001422:Bacterial Adhesion; D041963:Bacteroidetes / Q000235:genetics / Q000276:immunology* / Q000502:physiology*; D003179:Complement C3b / Q000276:immunology / Q000378:metabolism; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D050296:Microbial Viability / Q000187:drug effects*; D044967:Serum / Q000276:immunology* / Q000382:microbiology*
D008562:Membrane Glycoproteins; C055764:S-layer proteins; D003179:Complement C3b